EMAS position statement: Management of uterine fibroids

Maturitas

Volumn 79, Issue 1, 2014, Pages 106-116

  Pérez López, Faustino R ^a   Ornat, Lía ^a   Ceausu, Iuliana ^b,c   Depypere, Herman ^d   Erel, C Tamer ^e   Lambrinoudaki, Irene ^f   Schenck Gustafsson, Karin ^g   Simoncini, Tommaso ^h   Tremollieres, Florence ⁱ   Rees, Margaret ^j  

^a UNIVERSITY OF ZARAGOZA   (Spain)

^b CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^c CANTACUZINO INSTITUTE   (Romania)

^d GHENT UNIVERSITY HOSPITAL   (Belgium)

^e ISTANBUL UNIVERSITY   (Turkey)

^f UNIVERSITY OF ATHENS   (Greece)

^g KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^h UNIVERSITY OF PISA   (Italy)

ⁱ Paul Sabatier University   (France)

^j JOHN RADCLIFFE HOSPITAL   (United Kingdom)

more..

Author keywords

Fibroids; Gn RH analogs; High intensity focused ultrasound; Hysterectomy; Myomectomy; Ulipristal; Uterine artery embolization

Indexed keywords

ANTIGESTAGEN; GONADORELIN; NONSTEROID ANTIINFLAMMATORY AGENT; PROGESTERONE RECEPTOR MODULATOR; STEROID; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT; GESTAGEN; PROGESTERONE RECEPTOR;

ARTERY LIGATION; ARTICLE; CONSERVATIVE TREATMENT; DYSMENORRHEA; ENDOMETRIUM ABLATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; HYSTERECTOMY; INFERTILITY; LAPAROSCOPIC SURGERY; LEIOMYOSARCOMA; MALIGNANT TRANSFORMATION; MENORRHAGIA; MYOMECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIC PAIN; PREVALENCE; RADIOFREQUENCY ABLATION; ROBOTICS; TUMOR GROWTH; UTERINE ARTERY EMBOLIZATION; UTERUS MYOMA; ANTAGONISTS AND INHIBITORS; ARTIFICIAL EMBOLIZATION; DECISION MAKING; FEMALE; INTERVENTIONAL RADIOLOGY; LEIOMYOMA; PATIENT CARE PLANNING; PRACTICE GUIDELINE; PROCEDURES; TREATMENT OUTCOME; UTERINE HEMORRHAGE; UTERINE NEOPLASMS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIFIBRINOLYTIC AGENTS; DECISION MAKING; EMBOLIZATION, THERAPEUTIC; FEMALE; GONADOTROPIN-RELEASING HORMONE; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; HUMANS; HYSTERECTOMY; LEIOMYOMA; PATIENT CARE PLANNING; PELVIC PAIN; PROGESTINS; RADIOLOGY, INTERVENTIONAL; RECEPTORS, PROGESTERONE; TREATMENT OUTCOME; UTERINE HEMORRHAGE; UTERINE MYOMECTOMY; UTERINE NEOPLASMS;

EID: 84906303708     PISSN: 03785122     EISSN: 18734111     Source Type: Journal    
DOI: 10.1016/j.maturitas.2014.06.002     Document Type: Article

References (150)

1. S.E. Bulun Uterine fibroids N Engl J Med 369 2013 1344 1355
2. M. Ono, P. Yin, and A. Navarro et al. Paracrine activation of WNT/β-catenin pathway in uterine leiomyoma stem cells promotes tumor growth Proc Natl Acad Sci USA 110 2013 17053 17058
3. E. Bertsch, W. Qiang, and Q. Zhang et al. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma Mod Pathol 2014 [in press], PMID: 24390224
4. G.P. Flake, A.B. Moore, and D. Sutton et al. The natural history of uterine leiomyomas: light and electron microscopic studies of fibroid phases, interstitial ischemia, inanosis, and reclamation Obstet Gynecol Int 2013 2013 528376
5. L.L. Nikitenko, T. Cross, and L. Campo et al. Expression of terminally glycosylated calcitonin receptor-like receptor in uterine leiomyoma: endothelial phenotype and association with microvascular density Clin Cancer Res 12 2006 5648 5658
6. R. Tal, and J.H. Segars The role of angiogenic factors in fibroid pathogenesis: potential implications for future therapy Hum Reprod Update 202 2014 194 216
7. T. Maruo, N. Ohara, J. Wang, and H. Matsuo Sex steroidal regulation of uterine leiomyoma growth and apoptosis Hum Reprod Update 10 2004 207 220
8. M.S. Islam, O. Protic, and S.R. Giannubilo et al. Uterine leiomyoma: available medical treatments and new possible therapeutic options J Clin Endocrinol Metab 98 2013 921 934
9. B.J. Borah, W.K. Nicholson, L. Bradley, and E.A. Stewart The impact of uterine leiomyomas: a national survey of affected women Am J Obstet Gynecol 209 2013 319.e1 319.e20
10. D.D. Baird, D.B. Dunson, M.C. Hill, D. Cousins, and J.M. Schectman High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence Am J Obstet Gynecol 188 2003 100 107
11. L.A. Wise, J.R. Palmer, and B.L. Harlow et al. Reproductive factors, hormonal contraception, and risk of uterine leiomyomata in African-American women: a prospective study Am J Epidemiol 159 2004 113 123
12. A.O. Hammoud, R. Asaad, J. Berman, M.C. Treadwell, S. Blackwell, and M.P. Diamond Volume change of uterine myomas during pregnancy: do myomas really grow? J Minim Invasive Gynecol 13 2006 386 390
13. R. Neiger, J.D. Sonek, C.S. Croom, and G. Ventolini Pregnancy-related changes in the size of uterine leiomyomas J Reprod Med 51 2006 671 674
14. C.R. Chen, G.M. Buck, N.G. Courey, K.M. Perez, and J. Wactawski-Wende Risk factors for uterine fibroids among women undergoing tubal sterilization Am J Epidemiol 153 2001 20 26
15. S.K. Laughlin, A.H. Herring, and D.A. Savitz et al. Pregnancy-related fibroid reduction Fertil Steril 94 2010 2421 2423
16. S. Okolo Incidence, aetiology and epidemiology of uterine fibroids Best Pract Res Clin Obstet Gynaecol 22 2008 571 588
17. L.A. Wise, J.R. Palmer, and B.L. Harlow et al. Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study Hum Reprod 19 2004 1746 1754
18. S.K. Laughlin, J.C. Schroeder, and D.D. Baird New directions in the epidemiology of uterine fibroids Semin Reprod Med 28 2010 204 217
19. J. Ott, C. Kurz, R. Braun, R. Promberger, R. Seemann, E. Vytiska-Binstorfer, and K. Walch Overt hypothyroidism is associated with the presence of uterine leiomyoma: a retrospective analysis Eur J Obstet Gynecol Reprod Biol 177 2014 19 22
20. L.A. Wise, R.G. Radin, J.R. Palmer, S.K. Kumanyika, D.A. Boggs, and L. Rosenberg Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata Am J Clin Nutr 94 2011 1620 1631
21. L.A. Wise, J.R. Palmer, E. Ruiz-Narvaez, D.E. Reich, and L. Rosenberg Is the observed association between dairy intake and fibroids in African Americans explained by genetic ancestry? Am J Epidemiol 178 2013 1114 1119
22. L.A. Wise, R.G. Radin, S.K. Kumanyika, E.A. Ruiz-Narváez, J.R. Palmer, and L. Rosenberg Prospective study of dietary fat and risk of uterine leiomyomata Am J Clin Nutr 99 2014 1105 1116
23. L. Yu, A.B. Moore, and L. Castro et al. Estrogen regulates MAPK-related genes through genomic and nongenomic interactions between IGF-1-I receptor tyrosine kinase and estrogen receptor-alpha signaling pathways in human uterine leiomyoma cells J Signal Transduct 2012 204236
24. Y. Shen, Q. Xu, J. Xu, M.L. Ren, and Y.L. Cai Environmental exposure and risk of uterine leiomyoma: an epidemiologic survey Eur Rev Med Pharmacol Sci 17 2013 3249 3256
25. M.G. Munro, H.O. Critchley, M.S. Broder, and I.S. Fraser FIGO Working Group on Menstrual Disorders. FIGO classification system (PALM-COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age Int J Gynaecol Obstet 113 2011 3 13
26. E. Dreisler, L.G. Poulsen, and S.L. Antonsen et al. EMAS clinical guide: assessment of the endometrium in peri and postmenopausal women Maturitas 75 2013 181 190
27. G.A. Bachmann, L.A. Bahouth, P. Amalraj, V. Mhamunkar, K. Hoes, and C.V. Ananth Uterine fibroids: correlations of anemia and pain to fibroid location and uterine weight J Reprod Med 56 2011 463 466
28. K. Puri, A.O. Famuyide, P.J. Erwin, E.A. Stewart, and S.K. Laughlin-Tommaso Submucosal fibroids and the relation to heavy menstrual bleeding and anemia Am J Obstet Gynecol 210 2014 38.e1 38.e7
29. U. Schumacher, J. Schumacher, U. Mellinger, C. Gerlinger, A. Wienke, and J. Endrikat Estimation of menstrual blood loss volume based on menstrual diary and laboratory data BMC Women's Health 12 2012 24
30. M. Napolitano, A. Dolce, and G. Celenza et al. Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses Ann Hematol 93 2014 557 563
31. T. Kavvadias, K. Baessler, and B. Schuessler Pelvic pain in urogynaecology: Part I: Evaluation, definitions and diagnoses Int Urogynecol J 22 2011 385 393
32. M. Moshesh, A.F. Olshan, T. Saldana, and D. Baird Examining the relationship between uterine fibroids and dyspareunia among premenopausal women in the United States J Sex Med 11 2014 800 808
33. B. Kroon, N. Johnson, M. Chapman, A. Yazdani, and R. Hart Australasian CREI Consensus Expert Panel on Trial evidence (ACCEPT) group. Fibroids in infertility - consensus statement from ACCEPT (Australasian CREI Consensus Expert Panel on Trial evidence) Aust N Z J Obstet Gynaecol 51 2011 289 295
34. M. Metwally, C.M. Farquhar, and T.C. Li Is another meta-analysis on the effects of intramural fibroids on reproductive outcomes needed? Reprod Biomed Online 23 2011 2 14
35. E. Somigliana, S. De Benedictis, and P. Vercellini et al. Fibroids not encroaching the endometrial cavity and IVF success rate: a prospective study Hum Reprod 26 2011 834 839
36. M. Metwally, Y.C. Cheong, and A.W. Horne Surgical treatment of fibroids for subfertility Cochrane Database Syst Rev 11 2012 CD003857
37. J. Shwayder, and K. Sakhel Imaging for uterine myomas and adenomyosis J Minim Invasive Gynecol 21 2014 362 376
38. G. Lefebvre, G. Vilos, and C. Allaire et al. The management of uterine leiomyomas J Obstet Gynaecol Can 25 2003 396
39. S.K. Laughlin, and E.A. Stewart Uterine leiomyomas: individualizing the approach to a heterogeneous condition Obstet Gynecol 117 2011 396 403
40. E.A. Pritts, and D.L. Olive When should uterine fibroids be treated? Curr Obstet Gynecol Rep 1 2012 71 80
41. I.S. Fraser, R.J. Porte, P.A. Kouides, and A.S. Lukes A benefit-risk review of systemic haemostatic agents: Part 2: In excessive or heavy menstrual bleeding Drug Saf 31 2008 275 282
42. E.W. Freeman, A. Lukes, and D. VanDrie et al. A dose-response study of a novel, oral tranexamic formulation for heavy menstrual bleeding Am J Obstet Gynecol 205 2011 319.e1 319.e7
43. S. Eder, J. Baker, J. Gersten, R.G. Mabey, and T.L. Adomako Efficacy and safety of oral tranexamic acid in women with heavy menstrual bleeding and fibroids Women's Health (Lond, Engl) 9 2013 397 403
44. B. Naoulou, and M.C. Tsai Efficacy of tranexamic acid in the treatment of idiopathic and non-functional heavy menstrual bleeding: a systematic review Acta Obstet Gynecol Scand 91 2012 529 537
45. P.P. Ip, K.W. Lam, and C.L. Cheung et al. Tranexamic acid-associated necrosis and intralesional thrombosis of uterine leiomyomas: a clinicopathologic study of 147 cases emphasizing the importance of drug-induced necrosis and early infarcts in leiomyomas Am J Surg Pathol 3 2007 1215 1224
46. A. Lethaby, K. Duckitt, and C. Farquhar Non-steroidal anti-inflammatory drugs for heavy menstrual bleeding Cochrane Database Syst Rev 1 2013 CD000400
47. J. Qin, T. Yang, F. Kong, and Q. Zhou Oral contraceptive use and uterine leiomyoma risk: a meta-analysis based on cohort and case-control studies Arch Gynecol Obstet 288 2013 139 148
48. F. Hoellen, G. Griesinger, and M.K. Bohlmann Therapeutic drugs in the treatment of symptomatic uterine fibroids Expert Opin Pharmacother 14 2013 2079 2085
49. S. Venkatachalam, J.S. Bagratee, and J. Moodley Medical management of uterine fibroids with medroxyprogesterone acetate (Depo Provera): a pilot study J Obstet Gynaecol 24 2004 798 800
50. S. Ichigo, H. Takagi, K. Matsunami, N. Suzuki, and A. Imai Beneficial effects of dienogest on uterine myoma volume: a retrospective controlled study comparing with gonadotropin-releasing hormone agonist Arch Gynecol Obstet 284 2011 667 670
51. U.S. Sangkomkamhang, P. Lumbiganon, M. Laopaiboon, and B.W. Mol Progestogens or progestogen-releasing intrauterine systems for uterine fibroids Cochrane Database Syst Rev 2 2013 CD008994
52. A.E. Lethaby, I. Cooke, and M. Rees Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding Cochrane Database Syst Rev 4 2005 CD002126
53. D. Socolov, I. Blidaru, B. Tamba, N. Miron, L. Boiculese, and R. Socolov Levonorgestrel releasing-intrauterine system for the treatment of menorrhagia and/or frequent irregular uterine bleeding associated with uterine leiomyoma Eur J Contracept Reprod Health Care 16 2011 480 487
54. A. Kriplani, D. Awasthi, V. Kulshrestha, and N. Agarwal Efficacy of the levonorgestrel-releasing intrauterine system in uterine leiomyoma Int J Gynaecol Obstet 116 2012 35 38
55. H.T. Depypere, T. Hillard, and R. Erkkola et al. A 60-month non-comparative study on bleeding profiles with the levonorgestrel intrauterine system from the late transition period to estrogen supplemented menopause Eur J Obstet Gynecol Reprod Biol 153 2010 176 180
56. Q. Xu, L. Qiu, L. Zhu, L. Luo, and C. Xu Levonorgestrel inhibits proliferation and induces apoptosis in uterine leiomyoma cells Contraception 82 2010 301 308
57. W. Jiang, Q. Shen, and M. Chen et al. Levonorgestrel-releasing intrauterine system use in premenopausal women with symptomatic uterine leiomyoma: a systematic review Steroids 86C 2014 69 78
58. J. Youm, H.J. Lee, S.K. Kim, H. Kim, and B.C. Jee Factors affecting the spontaneous expulsion of the levonorgestrel-releasing intrauterine system Int J Gynaecol Obstet 2014 [in press]
59. F.R. Pérez-López Long-term consequences of LNG-IUS vs. hysterectomy for menorrhagia Climacteric 14 2014 308 309
60. L. Muzii, T. Boni, and F. Bellati et al. GnRH analogue treatment before hysteroscopic resection of submucous myomas: a prospective, randomized, multicenter study Fertil Steril 94 2010 1496 1499
61. A. Lethaby, B. Vollenhoven, and M. Sowter Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review BJOG 109 10 2002 1097 1108
62. A.E. Lethaby, and B.J. Vollenhoven An evidence-based approach to hormonal therapies for premenopausal women with fibroids Best Pract Res Clin Obstet Gynaecol 22 2008 307 331
63. M.S. Kamath, E.E. Kalampokas, and T.E. Kalampokas Use of GnRH analogues pre-operatively for hysteroscopic resection of submucous fibroids: a systematic review and meta-analysis Eur J Obstet Gynecol Reprod Biol 177C 2014 11 18
64. Q. Shen, Y. Hua, W. Jiang, W. Zhang, M. Chen, and X. Zhu Effects of mifepristone on uterine leiomyoma in premenopausal women: a meta-analysis Fertil Steril 100 2013 1722 1726
65. C. Feng, S. Meldrum, and K. Fiscella Improved quality of life is partly explained by fewer symptoms after treatment of fibroids with mifepristone Int J Gynaecol Obstet 109 2010 121 124
66. S.H. Eisinger, J. Fiscella, T. Bonfiglio, S. Meldrum, and K. Fiscella Open-label study of ultra low-dose mifepristone for the treatment of uterine leiomyomata Eur J Obstet Gynecol Reprod Biol 146 2009 215 218
67. M. Tristan, L.J. Orozco, A. Steed, A. Ramírez-Morera, and P. Stone Mifepristone for uterine fibroids Cochrane Database Syst Rev 8 2012 CD007687
68. G.M. Yerushalmi, Y. Gilboa, and A. Jakobson-Setton et al. Vaginal mifepristone for the treatment of symptomatic uterine leiomyomata: an open-label study Fertil Steril 101 2014 496 500
69. J. Wilkens, K. Chwalisz, and C. Han et al. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy J Clin Endocrinol Metab 93 2008 4664 4671
70. L.K. Nieman, W. Blocker, and T. Nansel et al. Efficacy and tolerability of CDB-2914 treatment for symptomatic uterine fibroids: a randomized, double-blind, placebo-controlled, phase IIb study Fertil Steril 95 2011 767 772 e1-e2
71. J. Donnez, T.F. Tatarchuk, and P. Bouchard et al. Ulipristal acetate versus placebo for fibroid treatment before surgery N Engl J Med 366 2012 409 420
72. J. Donnez, J. Tomaszewski, and F. Vázquez et al. Ulipristal acetate versus leuprolide acetate for uterine fibroids N Engl J Med 366 2012 421 432
73. N. Biglia, S. Carinelli, A. Maiorana, M. D'Alonzo, G. Lo Monte, and R. Marci Ulipristal acetate: a novel pharmacological approach for the treatment of uterine fibroids Drug Des Dev Ther 8 2014 285 292
74. J. Donnez, F. Vázquez, and J. Tomaszewski et al. Long-term treatment of uterine fibroids with ulipristal acetate Fertil Steril 101 2014 1565 1573 e18
75. L. Deng, T. Wu, X.Y. Chen, L. Xie, and J. Yang Selective estrogen receptor modulators (SERMs) for uterine leiomyomas Cochrane Database Syst Rev 10 2012 CD005287
76. F.K. Varelas, A.N. Papanicolaou, N. Vavatsi-Christaki, G.A. Makedos, and G.D. Vlassis The effect of anastrazole on symptomatic uterine leiomyomata Obstet Gynecol 110 2007 643 649
77. M.E. Parsanezhad, M. Azmoon, and S. Alborzi et al. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status Fertil Steril 93 2010 192 198
78. L.G. Brito, F.J. Candido-dos-Reis, F.A. Magario, and M.M. Sabino-de-Freitas Effect of the aromatase inhibitor anastrozole on uterine and leiomyoma Doppler blood flow in patients scheduled for hysterectomy: a pilot study Ultrasound Obstet Gynecol 40 2012 119 120
79. H. Song, D. Lu, K. Navaratnam, and G. Shi Aromatase inhibitors for uterine fibroids Cochrane Database Syst Rev 10 2013 CD009505
80. S. Hilario, N. Bozzini, R. Borsari, and E. Baracat Action of aromatase inhibitor for treatment of uterine leiomyoma in perimenopausal patients Fertil Steril 91 2009 240 243
81. N. Duhan, S. Madaan, and J. Sen Role of the aromatase inhibitor letrozole in the management of uterine leiomyomas in premenopausal women Eur J Obstet Gynecol Reprod Biol 171 2013 329 332
82. J.P. Liu, H. Yang, Y. Xia, and F. Cardini Herbal preparations for uterine fibroids Cochrane Database Syst Rev 4 2013 CD005292
83. Royal College of Obstetricians and Gynaecologists Consent advice 4: abdominal hysterectomy for benign conditions 2009 RCOG Press London
84. M. Sculpher, A. Manca, J. Abbott, J. Fountain, S. Mason, and R. Garry Cost effectiveness analysis of laparoscopic hysterectomy compared with standard hysterectomy: results from a randomised trial Br Med J 328 2004 134
85. T.E. Nieboer, N. Johnson, and A. Lethaby et al. Surgical approach to hysterectomy for benign gynaecological disease Cochrane Database Syst Rev 3 2009 CD003677
86. A. Lethaby, A. Mukhopadhyay, and R. Naik Total versus subtotal hysterectomy for benign gynaecological conditions Cochrane Database Syst Rev 4 2012 CD004993
87. E. Manoucheri, N. Fuchs-Weizman, S.L. Cohen, K.C. Wang, and J.I. Einarsson MAUDE - analysis of robotic-assisted gynecologic surgery J Minim Invasive Gynecol 2014 pii: S1553-4650(14)00027-2
88. P. Kannisto, P. Harter, F. Heitz, A. Traut, A. du Bois, and C. Kurzeder Implementation of robot-assisted gynecologic surgery for patients with low and high BMI in a German gynecological cancer center Arch Gynecol Obstet 290 2014 143 148
89. M. O'Neill, P.S. Moran, and C. Teljeur et al. Robot-assisted hysterectomy compared to open and laparoscopic approaches: systematic review and meta-analysis Arch Gynecol Obstet 287 2013 907 918
90. S.W. Sawin, N.D. Pilevsky, J.A. Berlin, and K.T. Barnhart Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas Am J Obstet Gynecol 183 2000 1448 1455
91. J. Pundir, N. Krishnan, and A. Siozos et al. Peri-operative morbidity associated with abdominal myomectomy for very large fibroid uteri Eur J Obstet Gynecol Reprod Biol 167 2013 219 224
92. L. Mettler, T. Schollmeyer, E. Lehmann-Willenbrock, J. Dowaji, and A. Zavala Treatment of myomas by laparoscopic and laparotomic myomectomy and laparoscopic hysterectomy Min Invas Ther Allied Technol 13 2004 58 64
93. C. Jin, Y. Hu, and X.C. Chen et al. Laparoscopic versus open myomectomy - a metaanalysis of randomized controlled trials Eur J Obstet Gynecol Reprod Biol 145 2009 14 21
94. K. Kubinova, M. Mara, P. Horak, D. Kuzel, and A. Dohnalova Reproduction after myomectomy: comparison of patients with and without second-look laparoscopy Minim Invasive Ther Allied Technol 21 2012 118 124
95. D. Soriano, L. Desolle, C. Poncelet, J.L. Benifla, P. Madelenat, and E. Darai Pregnancy outcome after laparoscopic and laparoconverted myomectomy Eur J. Obstet Gynecol Reprod Biol 108 2003 194 198
96. A. Hackethal, A. Westermann, and G. Tchartchian et al. Laparoscopic myomectomy in patients with uterine myomas associated with infertility Minim Invasive Ther Allied Technol 20 2011 338 345
97. P.G. Paul, A.K. Koshy, and T. Thomas Pregnancy outcomes following laparoscopic myomectomy and single-layer myometrial closure Hum Reprod 21 2006 3278 3281
98. T. Banas, M. Klimek, A. Fugiel, and K. Skotniczny Spontaneous uterine rupture at 35 weeks' gestation, 3 years after laparoscopic myomectomy, without signs of fetal distress J Obstet Gynaecol Res 31 2005 527 530
99. W.H. Parker, K. Iacampo, and T. Long Uterine rupture after laparoscopic removal of a pedunculated myoma J Minim Invasive Gynecol 14 2007 362 364
100. S.Y. Brucker, M. Hahn, D. Kraemer, F.A. Taran, K.B. Isaacson, and B. Krämer Laparoscopic radiofrequency volumetric thermal ablation of fibroids versus laparoscopic myomectomy Int J Gynecol Obstet 125 2014 261 265
101. US Food and Drug Administration Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication 2014 http://www.fda.gov/medicaldevices/safety/alertsandnotices/ucm393576.htm [accessed 05.06.14]
102. A.P. Advincula, X. Xu, S. Goudeau 4th, and S.B. Ransom Robot-assisted laparoscopic myomectomy versus abdominal myomectomy: a comparison of short-term surgical outcomes and immediate costs J Minim Invasive Gynecol 14 2007 698 705
103. F.W. Mansour, S. Kives, D.R. Urbach, and G. Lefebvre Robotically assisted laparoscopic myomectomy: a Canadian experience J Obstet Gynaecol Can 34 2012 353 358
104. N. Ranisavljevic, G. Mercier, F. Masia, P. Mares, R. De Tayrac, and G. Triopon Robot-assisted laparoscopic myomectomy: comparison with abdominal myomectomy J Gynecol Obstet Biol Reprod (Paris) 41 2012 439 444
105. M.C. Pitter, A.R. Gargiulo, L.M. Bonaventura, J.S. Lehman, and S.S. Srouji Pregnancy outcomes following robot-assisted myomectomy Hum Reprod 28 2013 99 108
106. P.C. Brady, A.K. Stanic, and A.K. Styer Uterine fibroids and subfertility: an update on the role of myomectomy Curr Opin Obstet Gynecol 25 2013 255 259
107. M.L. Casini, F. Rossi, R. Agostini, and V. Unfer Effects of the position of fibroids on fertility Gynecol Endocrinol 22 2006 106 109
108. J. Bosteels, J. Kasius, S. Weyers, F.J. Broekmans, B.W. Mol, and T.M. D'Hooghe Hysteroscopy for treating subfertility associated with suspected major uterine cavity abnormalities Cochrane Database Syst Rev 1 2013 CD009461
109. A. Helal, Mashaly Ael-M, and T. Amer Uterine artery occlusion for treatment of symptomatic uterine myomas JSLS 14 2010 386 390
110. W.C. Chang, P.S. Huang, and P.H. Wang et al. Comparison of laparoscopic myomectomy using in situ morcellation with and without uterine artery ligation for treatment of symptomatic myomas J Minim Invasive Gynecol 19 2012 715 721
111. G. Vercellino, E. Erdemoglu, and A. Joe et al. Laparoscopic temporary clipping of uterine artery during laparoscopic myomectomy Arch Gynecol Obstet 286 2012 1181 1186
112. O.I. Akinola, A.O. Fabamwo, R.A. Akinola, T.A. Ottun, A. Akinniyi, and A.E. Akpan Uterine artery ligation for the treatment of fibroids Acta Obstet Gynecol Scand 88 2009 59 62
113. M. Agdi, and T. Tulandi The benefits of intrauterine balloon: an intrauterine manipulator and balloon proved useful in myomectomy Am J Obstet Gynecol 199 2008 581.e1
114. ® for heavy menstrual bleeding: a systematic review of clinical effectiveness and cost-effectiveness analysis Health Technol Assess 15 2011 iii xvi 1-252
115. R.J. Fergusson, A. Lethaby, S. Shepperd, and C. Farquhar Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding Cochrane Database Syst Rev 11 2013 CD000329
116. J. Kroft, and G. Liu First- versus second-generation endometrial ablation devices for treatment of menorrhagia: a systematic review, meta-analysis and appraisal of economic evaluations J Obstet Gynaecol Can 35 2013 1010 1019
117. G. Tropeano, S. Amoroso, and G. Scambia Non-surgical management of uterine fibroids Hum Reprod Update 14 2008 259 274
118. O. Wu, A. Briggs, and S. Dutton et al. Uterine artery embolisation or hysterectomy for the treatment of symptomatic uterine fibroids: a cost-utility analysis of the HOPEFUL study BJOG 114 2007 1352 1362
119. J.H. You, D.S. Sahota, and P.M. Yuen Uterine artery embolization, hysterectomy, or myomectomy for symptomatic uterine fibroids: a cost-utility analysis Fertil Steril 91 2009 580 588
120. R.D. Edwards, J.G. Moss, and M.A. Lumsden et al. Committee of the randomized trial of embolization versus surgical treatment for fibroids: uterine-artery embolization versus surgery for symptomatic uterine fibroids N Engl J Med 356 2007 360 370
121. J.G. Moss, K.G. Cooper, and A. Khaund et al. Randomised comparison of uterine artery embolisation (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial): 5-year results BJOG 118 2011 936 944
122. J.K. Gupta, A. Sinha, M.A. Lumsden, and M. Hickey Uterine artery embolization for symptomatic uterine fibroids Cochrane Database Syst Rev 5 2012 CD005073
123. W.J. Hehenkamp, N.A. Volkers, and F.J. Broekmans et al. Loss of ovarian reserve after uterine artery embolization: a randomized comparison with hysterectomy Hum Reprod 22 2007 1996 2005
124. J.F. Payne, S.J. Robboy, and A.F. Haney Embolic microspheres within ovarian arterial vasculature after uterine artery embolization Obstet Gynecol 100 2002 883 886
125. R.K. Ryu, H.B. Chrisman, and R.A. Omary et al. The vascular impact of uterine artery embolization: prospective sonographic assessment of ovarian arterial circulation J Vasc Interv Radiol 12 2001 1071 1074
126. G.R. Kaump, and J.B. Spies The impact of uterine artery embolization on ovarian function J Vasc Interv Radiol 24 2013 459 467
127. A. Torre, B. Paillusson, V. Fain, P. Labauge, J.P. Pelage, and A. Fauconnier Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms Hum Reprod 29 2014 490 501
128. R. Arthur, J. Kachura, G. Liu, C. Chan, and H. Shapiro Laparoscopic myomectomy versus uterine artery embolization: long-term impact on markers of ovarian reserve J Obstet Gynaecol Can 36 2014 240 247
129. T. Yamagami, R. Yoshimatsu, and T. Matsumoto et al. Fertility after uterine artery embolization: investigation using a sheep model Reprod Sci 17 2010 350 357
130. O.C. Smart, J.T. Hindley, L. Regan, and W.G. Gedroyc Gonadotrophin- releasing hormone and magnetic-resonance-guided ultrasound surgery for uterine leiomyomata Obstet Gynecol 108 2006 49 54
131. V. Froeling, K. Meckelburg, and N.F. Schreiter et al. Outcome of uterine artery embolization versus MR-guided high-intensity focused ultrasound treatment for uterine fibroids: long-term results Eur J Radiol 82 2013 2265 2269
132. V. Fröling, T.J. Kröncke, and N.F. Schreiter et al. Technical eligibility for treatment of magnetic resonance-guided focused ultrasound surgery Cardiovasc Intervent Radiol 37 2014 445 450
133. L. Zhang, W.Z. Chen, and Y.J. Liu et al. Feasibility of magnetic resonance imaging-guided high intensity focused ultrasound therapy for ablating uterine fibroids in patients with bowel lies anterior to uterus Eur J Radiol 73 2010 396 403
134. S. Gizzo, C. Saccardi, and T.S. Patrelli et al. Magnetic resonance-guided focused ultrasound myomectomy: safety, efficacy, subsequent fertility and quality-of-life improvements. A systematic review Reprod Sci 21 2014 465 476
135. W. Wang, Y. Wang, T. Wang, J. Wang, L. Wang, and J. Tang Safety and efficacy of US-guided high-intensity focused ultrasound for treatment of submucosal fibroids Eur Radiol 22 2012 2553 2558
136. W.P. Zhao, J.Y. Chen, and L. Zhang et al. Feasibility of ultrasound-guided high intensity focused ultrasound ablating uterine fibroids with hyperintense on T2-weighted MR imaging Eur J Radiol 82 2013 e43 e49
137. Y. Wang, W. Wang, and H. Ye Contrast-enhanced ultrasonography assessment of therapeutic efficacy for ultrasound-guided high-intensity focused ultrasound ablation of uterine fibroids: comparison with contrast-enhanced magnetic resonance J Med Ultrasound 22 2014 22 28
138. J.G. Garza-Leal, D. Toub, and I. Hernández León et al. Transcervical, intrauterine ultrasound-guided radiofrequency ablation of uterine fibroids with the VizAblate System: safety, tolerability, and ablation results in a closed abdomen setting Gynecol Surg 8 2011 327 334
139. V. Bergamini, F. Ghezzi, and A. Cromi et al. Laparoscopic radiofrequency thermal ablation: a new approach to symptomatic uterine myomas Am J Obstet Gynecol 192 2005 768 773
140. J.G. Garza-Leal, I. Hernandez Leon, L. Castillo Saenz, and B.B. Lee Laparoscopic ultrasound-guided radiofrequency volumetric thermal ablation of symptomatic uterine leiomyomas: feasibility study using the Halt 2000 Ablation System J Minim Invasive Gynecol 18 2011 364 371
141. R. Robles, V.A. Aguirre, A.I. Argueta, and M.R. Guerrero Laparoscopic radiofrequency volumetric thermal ablation of uterine myomas with 12 months of follow-up Int J Gynaecol Obstet 120 2013 65 69
142. S.G. Chudnoff, J.M. Berman, D.J. Levine, M. Harris, R.S. Guido, and E. Banks Outpatient procedure for the treatment and relief of symptomatic uterine myomas Obstet Gynecol 121 2013 1075 1082
143. N. Colacurci, P. De Franciscis, L. Cobellis, G. Nazzaro, and G. De Placido Effects of hormone replacement therapy on postmenopausal uterine myoma Maturitas 35 2000 167 173
144. C.H. Yang, J.N. Lee, S.C. Hsu, C.H. Kuo, and E.M. Tsai Effect of hormone replacement therapy on uterine fibroids in postmenopausal women - a 3-year study Maturitas 43 2002 35 39
145. M.R. Hendrickson, F.A. Tavassoli, and R.L. Kempson et al. Mesenchymal tumours and related lesions F.A. Tavassoli, P. Devilee, Pathology and genetics of tumours of the breast and female genital organs 2003 IARC Press Lyon, France 233 244
146. T. Namimoto, Y. Yamashita, and K. Awai et al. Combined use of T2-weighted and diffusion-weighted 3-T MR imaging for differentiating uterine sarcomas from benign leiomyomas Eur Radiol 19 2009 2756 2764
147. I. Thomassin-Naggara, S. Dechoux, and C. Bonneau et al. How to differentiate benign from malignant myometrial tumours using MR imaging Eur Radiol 23 2013 2306 2314
148. B. Davidson, V.M. Abeler, and M. Førsund et al. Gene expression signatures of primary and metastatic uterine leiomyosarcoma Hum Pathol 45 2014 691 700
149. H.J. Lehtonen Hereditary leiomyomatosis and renal cell cancer: update on clinical and molecular characteristics Fam Cancer 10 2011 397 411
150. D. Chourmouzi, E. Papadopoulou, and A. Drevelegas Magnetic resonance imaging findings in pseudo-Meigs' syndrome associated with a large uterine leiomyoma: a case report J Med Case Rep 4 2010 120